Menu

TechValidate Research on Philips Respironics: Trilogy Ventilator

25 TechFacts


Philips Respironics: Trilogy Ventilator Customer Statistic

4/5 Stars



82% of healthcare organizations rated Philips Respironics: Trilogy Ventilator as 4 stars or higher.

Philips Respironics: Trilogy Ventilator Customer Statistic

65% of healthcare organizations agreed that:

“Trilogy is the most trusted ventilator for use with pediatric patients.”

Philips Respironics: Trilogy Ventilator Customer Statistic

79% of healthcare organizations agreed that:

“When transitioning sensitive children from their critical care ventilator, Trilogy with Auto-Trak is the most effective ventilation choice for positive outcomes.”

Philips Respironics: Trilogy Ventilator Customer Statistic

79% of healthcare organizations agreed with the following statement:

“When transitioning sensitive children from their critical care ventilator, Trilogy with Auto-Trak is the most effective ventilation choice for positive outcomes.”

Philips Respironics: Trilogy Ventilator Customer Statistic

52% of surveyed healthcare organizations chose Trilogy for pediatric patients because of its ease of teaching family / caregivers.

52%

Philips Respironics: Trilogy Ventilator Customer Statistic

64% of surveyed healthcare organizations chose Trilogy for pediatric patients because of its ease of use.

64%

Philips Respironics: Trilogy Ventilator Customer Statistic

57% of surveyed healthcare organizations chose Trilogy because of AVAPS (Average Volume Assured Pressure Support).

57%

Philips Respironics: Trilogy Ventilator Customer Statistic

55% of surveyed healthcare organizations chose Trilogy because of Digital Auto-Trak.

55%

Philips Respironics: Trilogy Ventilator Customer Statistic

65% of healthcare organizations agreed with the following statement:

“The Philips Trilogy ventilator is the most trusted pediatric ventilator.”

Philips Respironics: Trilogy Ventilator Customer Statistic

60% of surveyed organizations achieved easier transitions to home by deploying Trilogy with Auto-Trak.

60%

Philips Respironics: Trilogy Ventilator Customer Statistic

53% of surveyed Healthcare organizations decreased hospital re-admissions for COPD patients by 50-74% or more with the Trilogy with AVAPS-AE.

53%

Philips Respironics: Trilogy Ventilator Customer Statistic

AVAPS-AE is the most commonly prescribed mode for Non-Invasive Ventilation COPD patients at 52% of surveyed Healthcare organizations.

52%

Philips Respironics: Trilogy Ventilator Customer Statistic

The Trilogy improved clinical efficacy for patients at 65% of surveyed Healthcare organizations.

Philips Respironics: Trilogy Ventilator Customer Statistic

Shortened Claim

The Trilogy with AVAPS-AE improved clinical efficacy for patients at 65% of surveyed Healthcare organizations.

Philips Respironics: Trilogy Ventilator Customer Statistic

The Trilogy with AVAPS-AE improved quality of life for patients at 80% of surveyed Healthcare organizations.

80%

Philips Respironics: Trilogy Ventilator Customer Statistic

The Trilogy with AVAPS-AE is proven to reduce hospital readmissions for patients at 68% of surveyed Healthcare organizations.

Philips Respironics: Trilogy Ventilator Customer Testimonial

AVAPS AE has proved useful in helping to determine settings when patients have used standard bi-level in ED or in post extubation support needs when OSA needs are not yet fully determined.

Respiratory Therapist, Small Business Health Care Company

Philips Respironics: Trilogy Ventilator Customer Statement

The Trilogy provided ease of use, improved quality of life, improved clinical efficacy, reduced hospital readmissions, increased patient adherence to therapy, and weaning for patients at a small business health care company.

Philips Respironics: Trilogy Ventilator Customer Statistic

60% of surveyed Healthcare organizations who evaluated LTV purchased the Trilogy because of the Trilogy product quality and reputation.

Philips Respironics: Trilogy Ventilator Customer Statistic

52% of surveyed Healthcare organizations who evaluated ResMed Astral purchased the Trilogy because of AVAPS AE specifically for the COPD population.

Philips Respironics: Trilogy Ventilator Customer Testimonial

The Trilogy allows us to offer a mode of non-invasive ventilation to help control some of our COPD patients readmissions to the hospital, and decrease the amount of flare ups the patients experience during their daily activities. I believe it allows them to live a more normal life with COPD.

Respiratory Therapist, Medium Enterprise Professional Services Company

Philips Respironics: Trilogy Net Promotor Score

94% of Healthcare organizations are likely to recommend Philips Respironics: Trilogy Ventilator.*

*Based on respondents who rated their likelihood to recommend as 7 or higher on a scale of 0 to 10.

Philips Respironics: Trilogy Ventilator Customer Satisfaction

94% of Healthcare organizations are likely to recommend Philips Respironics: Trilogy Ventilator.*

*Based on respondents who rated their likelihood to recommend as 7 or higher on a scale of 0 to 10.

Philips Respironics: Trilogy Ventilator Customer Testimonial

My 60 + patient load has shown to have decreased hospital admissions, improved quality of life, and an overall positive effect on their every day lives. In addition, the doctors like the reports I send them on a monthly basis.

Jim Gualdoni, Respiratory Manager, Medical West

53% of surveyed Healthcare organizations decreased hospital re-admissions for COPD patients by 50-74% or more with the Trilogy with AVAPS AE.




More Research on Philips Respironics: Trilogy Ventilator